Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s ...

Revenue: Total revenue was $2.1 million for the quarter ended September 30, 2024, comprised of $0.6 million in net product revenue for neffy sales, which reflects revenues from only one week following ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for ...

Twice a year, Kennesaw State University’s Office of Undergraduate Research hosts the Symposium of Student Scholars as an opportunity for students to showcase the research they’re conducting. In-person ...

Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD) to sustain heart function. However, despite improvements managing ...

Severe coronary artery calcification in patients with CKD increases the risk for heart failure, heart valve calcification, and progression to kidney failure.

Systolic congestive heart failure is when the left side of the heart weakens, and the heart can't pump effectively. It can cause a variety of symptoms.

High blood pressure is linked to a myocardial anatomical change called LVH. Learn how to offset left ventricular thickening ...

Worsening heart failure threatened the travel and family time Herman Davis and his wife cherished. But for nearly 3 years, a heart pump called a VAD has given him a quality of life back.

In this edition of Cardiology in the Young, Anderson et al. try to rejuvenate the long-standing discussion about the nature of the “ventricular septal defect” in hearts with double-outlet right ...